Biochemical Predictors of Necrotizing Enterocolitis

坏死性小肠结肠炎的生化预测因素

基本信息

  • 批准号:
    8068863
  • 负责人:
  • 金额:
    $ 12.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-05-21 至 2013-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The candidate, Katherine E. Gregory, PhD, RN, aims to become an independent clinical investigator who will lead her field in an innovative program of patient-oriented research. Dr. Gregory's program of research will generate new models of disease pathogenesis and prediction using cutting-edge biochemical analysis (i.e. microbiome) and bioinformatic prediction strategies (i.e. metabolomics). As part of her research training and experience to date, she has identified clinical predictors of necrotizing enterocolitis (NEC) in premature infants. This work has extended knowledge of antecedents of NEC well beyond prematurity and demographics. Dr. Gregory will remain focused on NEC, one of the major unsolved problems of neonatal care, the most common gastrointestinal emergency experienced by premature infants, and the leading reason for aberrant nutrition, growth and neurodevelopment in premature infants. New paradigms are needed to understand NEC etiology and pathobiology, which will aid in our prediction of this and other diseases. The central hypothesis of the research proposed is that NEC may be predicted in a population of extremely low gestational age neonates using non-serum based biologic sample (i.e. urine and stool). The use of urine for biomarker assays and stool for biochemical prediction techniques has the advantage of a noninvasive approach that would not deplete the low gestational age infant of an already limited blood volume. Dr. Gregory will train in the scientific methods related to the human microbiome of gastrointestinal disease pathogenesis under the mentorship of W. Allan Walker, MD. She will work under the mentorship of Bruce Kristal, PhD in conducting the metabolomic and bioinformatic analyses for the purpose of disease prediction. Finally, Dr. Gregory will be mentored by Linda Van Marter, MD, MPH in the clinical setting where she will collect biologic sample, develop a specimen bank for future analysis, and conduct an epidemiologic investigation of clinical factors related to NEC. This mentorship team has been selected for a diversity of research expertise in areas including gastrointestinal disease, nutrition, microbiome analysis, metabolomics, and cutting-edge neonatal research. In sum, the candidate will work with seasoned mentors in a world-class research environment. She will be successful in her research and training aims. RELEVANCE: Despite advances in neonatal intensive care and significant gains in premature infant survival, necrotizing enterocolitis remains one of the most significant complications of premature birth. Disease prediction, a priority area in patient-oriented research, will revolutionize how we take care of patients and improve human health. New paradigms are needed to understand the pathogenesis of NEC, which will aid in our ability to predict this disease and in turn improve care for premature infants.
描述(由申请人提供):候选人凯瑟琳·E·格雷戈里,博士,RN,目标是成为一名独立的临床调查员,将领导她所在领域的以患者为中心的创新研究计划。格雷戈里博士的研究计划将利用尖端的生化分析(即微生物组)和生物信息学预测策略(即代谢组学)产生新的疾病发病机制和预测模型。作为她迄今为止的研究培训和经验的一部分,她已经确定了早产儿坏死性小肠结肠炎(NEC)的临床预测因素。这项工作扩大了对NEC先兆的了解,远远超出了早产儿和人口统计学的范围。格雷戈里博士将继续关注NEC,这是新生儿护理中尚未解决的主要问题之一,也是早产儿最常见的胃肠道急症,也是早产儿营养、生长和神经发育异常的主要原因。需要新的范式来理解NEC的病因学和病理生物学,这将有助于我们对这种疾病和其他疾病的预测。这项研究提出的中心假设是,可以使用非血清生物样本(即尿液和粪便)在极低胎龄新生儿中预测NEC。使用尿液进行生物标记物分析,使用粪便进行生化预测技术,具有非侵入性方法的优势,不会耗尽已经有限的血量的低胎龄婴儿。格雷戈里博士将在W.Allan Walker医学博士的指导下,培训与胃肠道疾病发病机制的人类微生物群相关的科学方法。她将在布鲁斯·克里斯托博士的指导下进行代谢和生物信息学分析,以预测疾病。最后,Gregory博士将在临床环境中接受Linda Van Marter医学博士和公共卫生硕士的指导,她将在那里收集生物样本,开发一个用于未来分析的样本库,并对与NEC相关的临床因素进行流行病学调查。该指导团队已被选中,在胃肠道疾病、营养、微生物组分析、代谢组学和尖端新生儿研究等领域拥有多样化的研究专业知识。总之,应聘者将在世界级的研究环境中与经验丰富的导师合作。她将在她的研究和培训目标上取得成功。 相关性:尽管新生儿重症监护取得进展,早产儿存活率显著提高,坏死性小肠结肠炎仍然是早产最重要的并发症之一。疾病预测是以患者为中心的研究中的一个优先领域,它将彻底改变我们照顾患者的方式,并改善人类健康。需要新的范式来理解NEC的发病机制,这将有助于我们预测这种疾病,并反过来改善对早产儿的护理。

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Necrotizing enterocolitis in the premature infant: neonatal nursing assessment, disease pathogenesis, and clinical presentation.
Immunologic Factors in Human Milk and Disease Prevention in the Preterm Infant.
  • DOI:
    10.1007/s40124-013-0028-2
  • 发表时间:
    2013-12
  • 期刊:
  • 影响因子:
    1.9
  • 作者:
    Gregory, Katherine E;Walker, W Allan
  • 通讯作者:
    Walker, W Allan
Research strategies that result in optimal data collection from the patient medical record.
  • DOI:
    10.1016/j.apnr.2010.02.004
  • 发表时间:
    2012-05
  • 期刊:
  • 影响因子:
    2.2
  • 作者:
    Gregory, Katherine E.;Radovinsky, Lucy
  • 通讯作者:
    Radovinsky, Lucy
Mode of Birth Influences Preterm Infant Intestinal Colonization With Bacteroides Over the Early Neonatal Period.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Katherine Elizabeth Gregory其他文献

Katherine Elizabeth Gregory的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Katherine Elizabeth Gregory', 18)}}的其他基金

The influence of the milk microbiome on inflammation of the preterm infant
乳汁微生物组对早产儿炎症的影响
  • 批准号:
    9766395
  • 财政年份:
    2018
  • 资助金额:
    $ 12.91万
  • 项目类别:
Biochemical Predictors of Necrotizing Enterocolitis
坏死性小肠结肠炎的生化预测因素
  • 批准号:
    7847449
  • 财政年份:
    2009
  • 资助金额:
    $ 12.91万
  • 项目类别:
Biochemical Predictors of Necrotizing Enterocolitis
坏死性小肠结肠炎的生化预测因素
  • 批准号:
    7707257
  • 财政年份:
    2009
  • 资助金额:
    $ 12.91万
  • 项目类别:

相似海外基金

Can antibiotics disrupt biogeochemical nitrogen cycling in the coastal ocean?
抗生素会破坏沿海海洋的生物地球化学氮循环吗?
  • 批准号:
    2902098
  • 财政年份:
    2024
  • 资助金额:
    $ 12.91万
  • 项目类别:
    Studentship
Metallo-Peptides: Arming Cyclic Peptide Antibiotics with New Weapons to Combat Antimicrobial Resistance
金属肽:用新武器武装环肽抗生素以对抗抗菌素耐药性
  • 批准号:
    EP/Z533026/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.91万
  • 项目类别:
    Research Grant
The role of RNA repair in bacterial responses to translation-inhibiting antibiotics
RNA修复在细菌对翻译抑制抗生素的反应中的作用
  • 批准号:
    BB/Y004035/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.91万
  • 项目类别:
    Research Grant
Towards the sustainable discovery and development of new antibiotics
迈向新抗生素的可持续发现和开发
  • 批准号:
    FT230100468
  • 财政年份:
    2024
  • 资助金额:
    $ 12.91万
  • 项目类别:
    ARC Future Fellowships
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
  • 批准号:
    EP/Y023528/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.91万
  • 项目类别:
    Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
  • 批准号:
    BB/Y007611/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.91万
  • 项目类别:
    Research Grant
The disulfide bond as a chemical tool in cyclic peptide antibiotics: engineering disulfide polymyxins and murepavadin
二硫键作为环肽抗生素的化学工具:工程化二硫多粘菌素和 murepavadin
  • 批准号:
    MR/Y033809/1
  • 财政年份:
    2024
  • 资助金额:
    $ 12.91万
  • 项目类别:
    Research Grant
Role of phenotypic heterogeneity in mycobacterial persistence to antibiotics: Prospects for more effective treatment regimens
表型异质性在分枝杆菌对抗生素持久性中的作用:更有效治疗方案的前景
  • 批准号:
    494853
  • 财政年份:
    2023
  • 资助金额:
    $ 12.91万
  • 项目类别:
    Operating Grants
Imbalance between cell biomass production and envelope biosynthesis underpins the bactericidal activity of cell wall -targeting antibiotics
细胞生物量产生和包膜生物合成之间的不平衡是细胞壁靶向抗生素杀菌活性的基础
  • 批准号:
    2884862
  • 财政年份:
    2023
  • 资助金额:
    $ 12.91万
  • 项目类别:
    Studentship
Narrow spectrum antibiotics for the prevention and treatment of soft-rot plant disease
防治植物软腐病的窄谱抗生素
  • 批准号:
    2904356
  • 财政年份:
    2023
  • 资助金额:
    $ 12.91万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了